Institutional Investors Increase Holdings in Abbott Laboratories Stock
1 report, 1 independent
Updated Oct 20
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Several institutional investors increased their positions in Abbott Laboratories shares during the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd grew its stake by 2.6%, while Jeppson Wealth Management LLC increased its holdings by 4.0% during the same period. CFS Investment Advisory Services LLC also lifted its position by 7.4% in the third quarter.
From dailypolitical.com
Why it matters
The increased buying activity by various investment firms suggests growing institutional confidence in Abbott Laboratories. This activity could influence the stock valuation of Abbott Laboratories.
From dailypolitical.com
Who's involved
- Abbott LaboratoriesThe healthcare product maker whose stock was purchased by institutional investors.
Keep exploring
The entities involved
-
Abbott Laboratories
American global health care and medical device products company
Related events
- The Schwab U.S. Dividend Equity ETF holds Abbott Laboratories, Merck, and Coca-Cola as among its top holdings.
- The Schwab U.S. Dividend Equity ETF now includes Procter & Gamble, Abbott Laboratories, and Merck among its top 10 holdings.
- Abbott Laboratories faces an FDA recall classification of its sensors, while Ken Fisher and Donald Trump engage in stock transactions.